Mar 22, 2010 2:36 PM
A variety of pills and supplements are on the market claiming to help with weight loss, but a Silicon Valley company has submitted a drug for Federal and Drug Administration approval that it says could help obese people lose 10 to 15 percent of their body weight within a year.
"We believe we have the first product that actually treats the cause of these diseases," said Peter Tam, president of Vivus, a biotech company with what could soon be the next blockbuster drug.
Called "Qnexa," it is a once daily pill to fight high blood pressure, diabetes, high cholesterol and obesity.
"So far, all the treatments that are available right now are able to achieve 3-5 percent of weight loss. We are the first treatment that is capable of achieving 10-15 percent weight loss within one year," said Tam.
Qnexa still needs final FDA approval before it can be sold.
Tam said the company expects to hear by October.
PLEASE HELP US MODERATE COMMENTS
Offensive or inappropriate comments are subject to removal. To report a comment, please e-mail us at email@example.com, and include the name of the story and information on the comment.
Thank you! KSBY.com